Founded in 2001, Universal Biosensors is a company that focuses on the design and development of electrochemical cells (strips) utilized alongside point-of-use devices. These devices find applications in diverse industries including healthcare (point of care), wine, food, and agriculture. The company’s objective is to establish a diverse range of biosensors in significant markets, aiming to create sustainable revenue streams.
Universal Biosensors (ASX: UBI)
- Home
- Universal Biosensors (ASX: UBI)
Here are the latest articles on Universal Biosensors (ASX: UBI)
Universal Biosensors receives FDA approval for its blood coagulation device
March 19, 2024
Aussie biosensor company Universal Biosensors (ASX: UBI) has received the US FDA 510(k) and CLIA Waiver approval for its Xprecia Prime Coagulation Analyzer as a Class II device. Xprecia Prime is a portable coagulation monitoring device that provides fast and accurate PT/INR testing (measuring how long it takes for blood to clot) specifically for patients
Universal Biosensors secures five more distributors for its Petrackr diabetes monitor
August 8, 2023
Bolstering its market presence and catering for growing demand from pet health conscious owners, Universal Biosensors (ASX: UBI) has secured partnerships with five new distribution partners for its Petrackr product. Petrackr is a biosensor tech product developed by Universal Biosensors, designed to monitor and track the level of blood glucose in real-time. These biomarkers hold
Universal Biosensors launches diabetes monitoring device for cats and dogs in the US
May 3, 2023
In the land of sugar and fat, health concerns for the general population are rising and this has extended towards our furry friends where diabetes in cats and dogs are a real risk which is being addressed by biotech company Universal Biosensors (ASX: UBI) and their blood sugar monitoring device. As the latest extension of
Universal Biosensors partners with Peter Mac for handheld cancer diagnosis device
September 14, 2021
A handheld device which can remotely diagnose the presence of cancer cells is on the horizon with biotech company Universal Biosensors (ASX: UBI) partnering with the Peter MacCallum Cancer Centre on the project. Under the agreement, Peter Mac will supply cancer patient samples to Universal Biosensors which will use the plasma samples in their trials
Universal Biosensors enters collaboration to diagnose cancer from a finger prick
April 13, 2021
Life expectancy rates following the diagnosis of cancer could soon be significantly improved through early detection if biotech company Universal Biosensors (ASX: UBI) is successful in their newest research collaboration aiming to instantly identify cancer cells from a simple finger prick. The research project will be part of an exclusive collaboration between Deakin University’s Institute
Universal Biosensors brings winetech device to US to boost quality of wine
January 27, 2021
The art of winemaking is getting ever more scientific and this will be accelerated in the United States with Universal Biosensors (ASX: UBI) hand-held element tester to commence distribution through the American wine industry. The Sentia™ Analyzer is a handheld device that enables winemakers to test various levels of acidity and sugars in their wine
Recent Articles
